Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.

Cancer. 2006 Jun 15;106(12):2664-71.

3.

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad II.

Cancer. 2004 Dec 15;101(12):2859-65.

4.

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.

Grigull L, Pulver N, Goudeva L, Sykora KW, Linderkamp C, Beilken A, Seidemann K, Schmid H, Welte K, Heuft HG.

Support Care Cancer. 2006 Sep;14(9):910-6. Epub 2006 Apr 19.

PMID:
16622651
5.

Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.

Cesaro S, Chinello P, De Silvestro G, Marson P, Picco G, Varotto S, Pittalis S, Zanesco L.

Support Care Cancer. 2003 Feb;11(2):101-6. Epub 2002 Nov 12.

PMID:
12560938
6.

Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications.

Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY.

Ann Oncol. 2013 Jul;24(7):1873-9. doi: 10.1093/annonc/mdt110. Epub 2013 Mar 21.

7.

Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.

Rutella S, Pierelli L, Sica S, Serafini R, Chiusolo P, Paladini U, Leone F, Zini G, D'Onofrio G, Leone G, Piccirillo N.

Cytotherapy. 2003;5(1):19-30.

PMID:
12745586
8.

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia.

Mousset S, Hermann S, Klein SA, Bialleck H, Duchscherer M, Bomke B, Wassmann B, Böhme A, Hoelzer D, Martin H.

Ann Hematol. 2005 Oct;84(11):734-41. Epub 2005 Jun 11.

PMID:
15951986
9.

Granulocyte transfusions in the G-CSF era. Where do we stand?

Robinson SP, Marks DI.

Bone Marrow Transplant. 2004 Nov;34(10):839-46. Review.

PMID:
15273712
10.

The value and practicality of granulocyte transfusion: a single oncology centre experience.

Al-Tanbal H, Al Humaidan H, Al-Nounou R, Roberts G, Tesfamichael K, Owaidah T.

Transfus Med. 2010 Jun;20(3):160-8. doi: 10.1111/j.1365-3148.2009.00988.x. Epub 2010 Jan 12.

PMID:
20070613
11.

Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.

Massey E, Paulus U, Doree C, Stanworth S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005341. doi: 10.1002/14651858.CD005341.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;6:CD005341.

PMID:
19160254
12.

Granulocyte transfusion experience in pediatric neutropenic fever: Splitted product can be an alternative?

Oymak Y, Ayhan Y, Karapinar TH, Devrim I, Ay Y, Sarihan H, Vergin C.

Transfus Apher Sci. 2015 Dec;53(3):348-52. doi: 10.1016/j.transci.2015.07.002. Epub 2015 Jul 20.

PMID:
26227312
13.

Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience.

Pham HP, Rogoza K, Stotler B, Duffy D, Parker-Jones S, Ginzburg Y, Bhatia M, Cairo M, Schwartz J.

J Pediatr Hematol Oncol. 2012 Nov;34(8):e332-6. doi: 10.1097/MPH.0b013e3182580d40.

PMID:
22858567
14.

Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions.

Atay D, Ozturk G, Akcay A, Yanasik M, Anak S, Devecioglu O.

J Pediatr Hematol Oncol. 2011 Aug;33(6):e220-5. doi: 10.1097/MPH.0b013e31821ffdf1.

PMID:
21792027
15.

Guidelines for safety management of granulocyte transfusion in Japan.

Ohsaka A, Kikuta A, Ohto H, Ohara A, Ishida A, Osada K, Tasaki T, Kamitamari A, Iwai A, Kai S, Maekawa T, Hoshi Y; Japan Society of Transfusion Medicine and Cell Therapy, Granulocyte Transfusion Task Force..

Int J Hematol. 2010 Mar;91(2):201-8. doi: 10.1007/s12185-010-0506-z. Epub 2010 Feb 11.

PMID:
20146029
16.

Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.

Grigull L, Schrauder A, Schmitt-Thomssen A, Sykora K, Welte K.

Infection. 2002 Oct;30(5):267-71.

PMID:
12382084
17.
18.

Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.

Stanworth SJ, Massey E, Hyde C, Brunskill S, Lucas G, Navarrete C, Marks DI.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005339. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD005339.

PMID:
16034970
19.
20.

Granulocyte transfusions in infected neutropenic children with malignancies.

Steinherz PG, Reich LM.

Med Pediatr Oncol. 1979;6(1):65-76.

PMID:
440206

Supplemental Content

Support Center